Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytodiagnosis | 13 | 2023 | 432 | 4.120 |
Why?
|
Lung Neoplasms | 59 | 2024 | 13221 | 3.380 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 27 | 2023 | 5241 | 2.430 |
Why?
|
Biopsy, Fine-Needle | 19 | 2024 | 1113 | 2.030 |
Why?
|
Thyroid Nodule | 7 | 2023 | 759 | 1.750 |
Why?
|
Specimen Handling | 5 | 2020 | 706 | 1.740 |
Why?
|
Thyroid Neoplasms | 11 | 2023 | 2327 | 1.630 |
Why?
|
Adenocarcinoma | 19 | 2023 | 6317 | 1.380 |
Why?
|
Adenocarcinoma, Follicular | 5 | 2023 | 325 | 1.370 |
Why?
|
Laboratories | 3 | 2022 | 460 | 1.270 |
Why?
|
Molecular Diagnostic Techniques | 5 | 2023 | 610 | 1.260 |
Why?
|
Thyroid Gland | 6 | 2022 | 1166 | 1.180 |
Why?
|
Bronchoscopy | 10 | 2022 | 898 | 0.890 |
Why?
|
Bronchi | 4 | 2021 | 845 | 0.770 |
Why?
|
Lung | 16 | 2024 | 9924 | 0.760 |
Why?
|
Salivary Glands | 1 | 2022 | 229 | 0.740 |
Why?
|
Granuloma | 2 | 2020 | 325 | 0.680 |
Why?
|
Receptor Protein-Tyrosine Kinases | 11 | 2022 | 1617 | 0.670 |
Why?
|
Antigens, CD1d | 2 | 2019 | 217 | 0.660 |
Why?
|
Societies, Scientific | 1 | 2019 | 220 | 0.620 |
Why?
|
Natural Killer T-Cells | 2 | 2019 | 309 | 0.610 |
Why?
|
Mediastinal Diseases | 1 | 2018 | 91 | 0.600 |
Why?
|
Neoplasm Staging | 13 | 2023 | 11106 | 0.600 |
Why?
|
Quality Assurance, Health Care | 2 | 2018 | 2176 | 0.580 |
Why?
|
Mutation | 18 | 2023 | 29764 | 0.580 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2016 | 57 | 0.550 |
Why?
|
Quality Improvement | 4 | 2021 | 3826 | 0.550 |
Why?
|
Societies, Medical | 4 | 2023 | 3858 | 0.540 |
Why?
|
Lymphangioleiomyomatosis | 1 | 2018 | 203 | 0.530 |
Why?
|
Humans | 120 | 2024 | 756111 | 0.440 |
Why?
|
Tomography, X-Ray Computed | 19 | 2024 | 20421 | 0.440 |
Why?
|
Diagnostic Errors | 3 | 2022 | 1259 | 0.430 |
Why?
|
Protein Kinase Inhibitors | 14 | 2023 | 5613 | 0.420 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 782 | 0.420 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2017 | 893 | 0.410 |
Why?
|
Pathology, Surgical | 2 | 2021 | 150 | 0.410 |
Why?
|
Multiple Pulmonary Nodules | 3 | 2020 | 164 | 0.410 |
Why?
|
Pathology, Clinical | 3 | 2022 | 367 | 0.410 |
Why?
|
Carcinoma, Papillary | 2 | 2021 | 786 | 0.400 |
Why?
|
Receptors, LDL | 2 | 2019 | 488 | 0.400 |
Why?
|
Heart Valve Diseases | 2 | 2021 | 1049 | 0.400 |
Why?
|
Small Cell Lung Carcinoma | 4 | 2020 | 417 | 0.400 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1746 | 0.390 |
Why?
|
Lymph Nodes | 3 | 2018 | 3480 | 0.380 |
Why?
|
Atherosclerosis | 4 | 2019 | 3514 | 0.380 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1114 | 0.370 |
Why?
|
Laboratories, Hospital | 3 | 2021 | 194 | 0.370 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1896 | 0.370 |
Why?
|
Solitary Pulmonary Nodule | 3 | 2019 | 268 | 0.370 |
Why?
|
Molecular Targeted Therapy | 4 | 2018 | 2788 | 0.370 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3603 | 0.360 |
Why?
|
Internet | 1 | 2022 | 3068 | 0.350 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2022 | 2497 | 0.350 |
Why?
|
Arteriosclerosis | 2 | 2005 | 1054 | 0.340 |
Why?
|
Endosonography | 3 | 2020 | 605 | 0.340 |
Why?
|
Retrospective Studies | 31 | 2023 | 79746 | 0.340 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2020 | 2818 | 0.340 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2018 | 561 | 0.320 |
Why?
|
Cholesterol, VLDL | 1 | 2008 | 71 | 0.310 |
Why?
|
Patient Care | 3 | 2023 | 626 | 0.290 |
Why?
|
Practice Guidelines as Topic | 6 | 2017 | 7439 | 0.290 |
Why?
|
Carcinoma | 2 | 2016 | 2344 | 0.290 |
Why?
|
Risk | 5 | 2023 | 9626 | 0.280 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11025 | 0.280 |
Why?
|
Calcinosis | 1 | 2015 | 1477 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2899 | 0.270 |
Why?
|
Pneumonia | 1 | 2018 | 2128 | 0.270 |
Why?
|
Idiopathic Pulmonary Fibrosis | 2 | 2022 | 492 | 0.260 |
Why?
|
DNA Mutational Analysis | 4 | 2018 | 4111 | 0.260 |
Why?
|
Aortic Valve | 1 | 2015 | 1992 | 0.250 |
Why?
|
Mediastinum | 2 | 2018 | 265 | 0.250 |
Why?
|
Lipoproteins | 3 | 2019 | 882 | 0.240 |
Why?
|
Precancerous Conditions | 1 | 2011 | 974 | 0.240 |
Why?
|
Argon Plasma Coagulation | 2 | 2021 | 25 | 0.240 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2019 | 5186 | 0.240 |
Why?
|
Adoptive Transfer | 1 | 2007 | 794 | 0.240 |
Why?
|
Female | 52 | 2023 | 388229 | 0.230 |
Why?
|
Gene Amplification | 3 | 2018 | 1081 | 0.230 |
Why?
|
Aged | 32 | 2021 | 167585 | 0.230 |
Why?
|
Genetic Testing | 1 | 2017 | 3506 | 0.230 |
Why?
|
Bronchial Neoplasms | 2 | 2014 | 110 | 0.230 |
Why?
|
Aged, 80 and over | 17 | 2020 | 58608 | 0.230 |
Why?
|
Biopsy, Needle | 5 | 2018 | 1633 | 0.220 |
Why?
|
Hemorheology | 1 | 2003 | 144 | 0.220 |
Why?
|
Prognosis | 11 | 2023 | 29463 | 0.220 |
Why?
|
Amoeba | 1 | 2023 | 20 | 0.220 |
Why?
|
Male | 43 | 2023 | 356852 | 0.210 |
Why?
|
Aortic Valve Stenosis | 1 | 2015 | 2066 | 0.210 |
Why?
|
Aortic Diseases | 1 | 2008 | 734 | 0.210 |
Why?
|
Tracheobronchomalacia | 2 | 2021 | 131 | 0.210 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2018 | 1704 | 0.200 |
Why?
|
Proto-Oncogene Proteins | 6 | 2017 | 4489 | 0.200 |
Why?
|
Pyrazoles | 4 | 2017 | 1983 | 0.200 |
Why?
|
Hand Deformities, Congenital | 1 | 2022 | 147 | 0.190 |
Why?
|
Curettage | 1 | 2021 | 73 | 0.190 |
Why?
|
Carbazoles | 2 | 2022 | 220 | 0.190 |
Why?
|
Amino Acyl-tRNA Synthetases | 1 | 2021 | 88 | 0.180 |
Why?
|
Cell Biology | 1 | 2021 | 90 | 0.180 |
Why?
|
Fatal Outcome | 4 | 2020 | 1829 | 0.180 |
Why?
|
Protein-Tyrosine Kinases | 4 | 2017 | 2410 | 0.180 |
Why?
|
Pyridines | 4 | 2017 | 2870 | 0.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2007 | 1757 | 0.170 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2020 | 58 | 0.170 |
Why?
|
Tracheal Stenosis | 1 | 2021 | 225 | 0.170 |
Why?
|
Middle Aged | 30 | 2021 | 218357 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9262 | 0.160 |
Why?
|
Neoplasms | 3 | 2022 | 21899 | 0.160 |
Why?
|
Pulmonary Sclerosing Hemangioma | 1 | 2018 | 2 | 0.160 |
Why?
|
Total Quality Management | 1 | 2020 | 267 | 0.160 |
Why?
|
Tomography, Optical Coherence | 2 | 2022 | 2853 | 0.160 |
Why?
|
Killer Cells, Natural | 2 | 2007 | 2181 | 0.160 |
Why?
|
Myositis | 1 | 2021 | 269 | 0.160 |
Why?
|
Tumor Burden | 3 | 2020 | 1888 | 0.160 |
Why?
|
Pleurodesis | 1 | 2018 | 41 | 0.150 |
Why?
|
Truth Disclosure | 1 | 2022 | 432 | 0.150 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2024 | 612 | 0.150 |
Why?
|
Prosthesis-Related Infections | 1 | 2023 | 484 | 0.150 |
Why?
|
Bronchiolitis | 1 | 2024 | 477 | 0.150 |
Why?
|
Trachea | 2 | 2021 | 1083 | 0.150 |
Why?
|
Lymphatic Metastasis | 2 | 2018 | 2937 | 0.150 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2020 | 749 | 0.150 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15228 | 0.150 |
Why?
|
Communicable Disease Control | 2 | 2022 | 844 | 0.140 |
Why?
|
Pacemaker, Artificial | 1 | 2023 | 814 | 0.140 |
Why?
|
Biopsy | 3 | 2022 | 6760 | 0.140 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 205 | 0.140 |
Why?
|
Microscopy, Fluorescence | 1 | 2024 | 2663 | 0.140 |
Why?
|
Needles | 1 | 2020 | 451 | 0.140 |
Why?
|
Thorax | 1 | 2020 | 552 | 0.140 |
Why?
|
Uterine Cervical Dysplasia | 1 | 2021 | 382 | 0.140 |
Why?
|
Antineoplastic Agents | 9 | 2018 | 13578 | 0.140 |
Why?
|
Cervix Uteri | 1 | 2021 | 585 | 0.140 |
Why?
|
Mediastinal Neoplasms | 1 | 2020 | 401 | 0.140 |
Why?
|
Leukocytes | 1 | 2005 | 2030 | 0.140 |
Why?
|
Exons | 2 | 2023 | 2385 | 0.140 |
Why?
|
Adaptive Immunity | 2 | 2019 | 721 | 0.140 |
Why?
|
Organ Specificity | 2 | 2016 | 1954 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14654 | 0.130 |
Why?
|
Genes, erbB-1 | 1 | 2017 | 160 | 0.130 |
Why?
|
Chondrosarcoma | 1 | 2018 | 293 | 0.130 |
Why?
|
False Positive Reactions | 1 | 2018 | 956 | 0.130 |
Why?
|
Benchmarking | 1 | 2022 | 1039 | 0.130 |
Why?
|
Carotid Artery, Internal | 1 | 2018 | 434 | 0.130 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 21 | 0.130 |
Why?
|
Airway Obstruction | 1 | 2020 | 655 | 0.120 |
Why?
|
HIV | 2 | 2023 | 1579 | 0.120 |
Why?
|
Neoplasm Invasiveness | 2 | 2020 | 3608 | 0.120 |
Why?
|
Adult | 21 | 2023 | 218302 | 0.120 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2014 | 76 | 0.120 |
Why?
|
Baths | 1 | 2014 | 53 | 0.120 |
Why?
|
Tissue Preservation | 1 | 2015 | 174 | 0.120 |
Why?
|
Workload | 1 | 2020 | 841 | 0.120 |
Why?
|
Metaplasia | 1 | 2015 | 320 | 0.120 |
Why?
|
Gene Rearrangement | 2 | 2017 | 1116 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2018 | 672 | 0.120 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2014 | 61 | 0.120 |
Why?
|
Autopsy | 1 | 2018 | 1005 | 0.120 |
Why?
|
Amyloidosis | 1 | 2021 | 813 | 0.120 |
Why?
|
Sputum | 1 | 2016 | 501 | 0.120 |
Why?
|
Water Microbiology | 1 | 2014 | 115 | 0.110 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2013 | 22 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 452 | 0.110 |
Why?
|
Piperidines | 2 | 2022 | 1643 | 0.110 |
Why?
|
Watchful Waiting | 1 | 2018 | 504 | 0.110 |
Why?
|
United States | 6 | 2023 | 71909 | 0.110 |
Why?
|
Tablets | 1 | 2014 | 149 | 0.110 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18009 | 0.110 |
Why?
|
Pulmonary Atelectasis | 1 | 2014 | 142 | 0.110 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1797 | 0.110 |
Why?
|
Respiratory Aspiration | 1 | 2014 | 84 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 890 | 0.110 |
Why?
|
Mesothelioma | 1 | 2019 | 830 | 0.110 |
Why?
|
Dyspnea | 2 | 2018 | 1347 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2023 | 1456 | 0.100 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2017 | 712 | 0.100 |
Why?
|
Workflow | 1 | 2017 | 843 | 0.100 |
Why?
|
Hypercalcemia | 1 | 2014 | 417 | 0.100 |
Why?
|
SEER Program | 1 | 2017 | 1524 | 0.100 |
Why?
|
Esophagitis | 1 | 2013 | 164 | 0.100 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4019 | 0.100 |
Why?
|
Aorta | 1 | 2019 | 2037 | 0.100 |
Why?
|
Thymoma | 1 | 2013 | 187 | 0.100 |
Why?
|
Mice, Knockout | 3 | 2019 | 14318 | 0.100 |
Why?
|
Retinoblastoma Protein | 1 | 2015 | 666 | 0.090 |
Why?
|
ras Proteins | 2 | 2013 | 1049 | 0.090 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 1418 | 0.090 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 588 | 0.090 |
Why?
|
Chest Pain | 1 | 2018 | 1105 | 0.090 |
Why?
|
Sirolimus | 1 | 2018 | 1534 | 0.090 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2018 | 2864 | 0.090 |
Why?
|
Radiography, Thoracic | 4 | 2020 | 1292 | 0.090 |
Why?
|
False Negative Reactions | 1 | 2011 | 573 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2015 | 344 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2015 | 1092 | 0.090 |
Why?
|
Adenoma, Oxyphilic | 1 | 2012 | 148 | 0.090 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 21780 | 0.090 |
Why?
|
Myasthenia Gravis | 1 | 2013 | 211 | 0.090 |
Why?
|
Strongyloidiasis | 1 | 2010 | 27 | 0.090 |
Why?
|
Child | 4 | 2023 | 79418 | 0.090 |
Why?
|
Cholesterol | 1 | 2019 | 2923 | 0.090 |
Why?
|
Jejunal Diseases | 1 | 2010 | 46 | 0.090 |
Why?
|
Terminology as Topic | 2 | 2021 | 1533 | 0.090 |
Why?
|
Foreign Bodies | 1 | 2014 | 394 | 0.090 |
Why?
|
Duodenal Diseases | 1 | 2010 | 99 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2017 | 6806 | 0.080 |
Why?
|
Schistosomiasis mansoni | 1 | 2010 | 90 | 0.080 |
Why?
|
Salivary Gland Neoplasms | 1 | 2013 | 302 | 0.080 |
Why?
|
Mice | 9 | 2019 | 80709 | 0.080 |
Why?
|
Diverticulum | 1 | 2010 | 138 | 0.080 |
Why?
|
Diet, Atherogenic | 1 | 2008 | 94 | 0.080 |
Why?
|
Intracranial Aneurysm | 1 | 2018 | 1239 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 2018 | 1402 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2021 | 2004 | 0.080 |
Why?
|
Immunocompetence | 1 | 2008 | 136 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3561 | 0.080 |
Why?
|
Communication | 1 | 2022 | 3830 | 0.080 |
Why?
|
Sheep | 2 | 2021 | 1437 | 0.080 |
Why?
|
Neoplasms, Second Primary | 1 | 2016 | 1059 | 0.080 |
Why?
|
Treatment Outcome | 9 | 2020 | 64582 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11607 | 0.070 |
Why?
|
Disease Progression | 5 | 2020 | 13432 | 0.070 |
Why?
|
Risk Factors | 5 | 2015 | 73898 | 0.070 |
Why?
|
Animals | 13 | 2021 | 167069 | 0.070 |
Why?
|
Receptor, erbB-2 | 1 | 2017 | 2487 | 0.070 |
Why?
|
Coronary Artery Disease | 1 | 2007 | 6625 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9479 | 0.070 |
Why?
|
Genomics | 3 | 2018 | 5742 | 0.070 |
Why?
|
Heart Valve Prosthesis | 1 | 2015 | 1501 | 0.070 |
Why?
|
Arteries | 1 | 2011 | 1115 | 0.070 |
Why?
|
Myocarditis | 1 | 2014 | 767 | 0.070 |
Why?
|
Feasibility Studies | 1 | 2017 | 5180 | 0.070 |
Why?
|
Thyroidectomy | 1 | 2012 | 901 | 0.070 |
Why?
|
Diagnosis, Differential | 5 | 2024 | 12950 | 0.070 |
Why?
|
Pyrimidines | 1 | 2018 | 2992 | 0.070 |
Why?
|
Pulmonary Artery | 1 | 2014 | 1928 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 3947 | 0.060 |
Why?
|
Models, Animal | 2 | 2020 | 2113 | 0.060 |
Why?
|
Genotype | 3 | 2015 | 12876 | 0.060 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4874 | 0.060 |
Why?
|
Young Adult | 4 | 2019 | 58143 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2015 | 1592 | 0.060 |
Why?
|
HIV Infections | 2 | 2023 | 17054 | 0.060 |
Why?
|
Liver Cirrhosis | 1 | 2014 | 1900 | 0.060 |
Why?
|
Lymphocyte Subsets | 1 | 2005 | 310 | 0.060 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 1132 | 0.050 |
Why?
|
Immunotherapy | 1 | 2018 | 4610 | 0.050 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2014 | 1452 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9259 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2018 | 16782 | 0.050 |
Why?
|
Immune System | 1 | 2007 | 794 | 0.050 |
Why?
|
Suction | 1 | 2023 | 264 | 0.050 |
Why?
|
Cholesterol, HDL | 1 | 2008 | 1811 | 0.050 |
Why?
|
Aniline Compounds | 2 | 2019 | 1058 | 0.050 |
Why?
|
Hyperlipidemias | 1 | 2007 | 782 | 0.050 |
Why?
|
Facies | 1 | 2022 | 198 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2286 | 0.050 |
Why?
|
Smad4 Protein | 1 | 2022 | 166 | 0.050 |
Why?
|
Argon | 1 | 2021 | 36 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2021 | 97 | 0.050 |
Why?
|
Tumor Necrosis Factors | 1 | 2021 | 102 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2014 | 2522 | 0.050 |
Why?
|
Immunosuppressive Agents | 1 | 2014 | 4093 | 0.050 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 5499 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2021 | 190 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2880 | 0.050 |
Why?
|
Triglycerides | 1 | 2008 | 2472 | 0.050 |
Why?
|
Planning Techniques | 1 | 2020 | 81 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 9054 | 0.040 |
Why?
|
Papillary Muscles | 1 | 2021 | 191 | 0.040 |
Why?
|
Survival Rate | 3 | 2020 | 12790 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2024 | 727 | 0.040 |
Why?
|
Elastin | 1 | 2021 | 300 | 0.040 |
Why?
|
Formaldehyde | 1 | 2021 | 357 | 0.040 |
Why?
|
Electrocoagulation | 1 | 2020 | 153 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 51 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4569 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2017 | 20002 | 0.040 |
Why?
|
Time Factors | 2 | 2020 | 39991 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 134 | 0.040 |
Why?
|
Cholesterol, LDL | 1 | 2008 | 2416 | 0.040 |
Why?
|
Adolescent | 4 | 2019 | 87297 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 98 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1106 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4296 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 561 | 0.040 |
Why?
|
Organizational Objectives | 1 | 2020 | 428 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15599 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1289 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2008 | 2631 | 0.040 |
Why?
|
Lasers, Solid-State | 1 | 2020 | 176 | 0.040 |
Why?
|
Vaginal Smears | 1 | 2021 | 495 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2021 | 1126 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39187 | 0.040 |
Why?
|
Acrylamides | 1 | 2019 | 257 | 0.040 |
Why?
|
Inflammation | 2 | 2021 | 10716 | 0.040 |
Why?
|
Immunity, Innate | 2 | 2011 | 3036 | 0.040 |
Why?
|
Pilot Projects | 2 | 2021 | 8498 | 0.040 |
Why?
|
Reference Standards | 1 | 2021 | 1004 | 0.040 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 1600 | 0.040 |
Why?
|
Amino Acids | 1 | 2023 | 1715 | 0.040 |
Why?
|
World Health Organization | 1 | 2023 | 1309 | 0.040 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 382 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2003 | 1776 | 0.030 |
Why?
|
Retreatment | 1 | 2018 | 599 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2007 | 5841 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2024 | 950 | 0.030 |
Why?
|
Incidental Findings | 1 | 2021 | 696 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2021 | 999 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2021 | 864 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5785 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8438 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 237 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1229 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2021 | 935 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2023 | 1263 | 0.030 |
Why?
|
Models, Biological | 2 | 2018 | 9453 | 0.030 |
Why?
|
Capnography | 1 | 2014 | 92 | 0.030 |
Why?
|
Medical Errors | 1 | 2022 | 1253 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 8917 | 0.030 |
Why?
|
Etoposide | 1 | 2015 | 629 | 0.030 |
Why?
|
Phosphorylation | 2 | 2015 | 8312 | 0.030 |
Why?
|
Radiography | 2 | 2015 | 6974 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2015 | 410 | 0.030 |
Why?
|
Luciferases | 1 | 2015 | 717 | 0.030 |
Why?
|
Fibrosis | 1 | 2020 | 2022 | 0.030 |
Why?
|
Video-Assisted Surgery | 1 | 2013 | 51 | 0.030 |
Why?
|
Autoantibodies | 1 | 2021 | 2093 | 0.030 |
Why?
|
Risk Assessment | 3 | 2023 | 23956 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3123 | 0.030 |
Why?
|
Cerebral Angiography | 1 | 2018 | 1260 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2003 | 3065 | 0.030 |
Why?
|
Mitral Valve | 1 | 2021 | 1483 | 0.030 |
Why?
|
Thymectomy | 1 | 2013 | 190 | 0.030 |
Why?
|
Antilymphocyte Serum | 1 | 2014 | 475 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 4890 | 0.030 |
Why?
|
Cytokines | 1 | 2007 | 7261 | 0.020 |
Why?
|
Mycophenolic Acid | 1 | 2014 | 338 | 0.020 |
Why?
|
Carboplatin | 1 | 2015 | 790 | 0.020 |
Why?
|
Hospitals, University | 1 | 2013 | 568 | 0.020 |
Why?
|
Genomic Instability | 1 | 2015 | 693 | 0.020 |
Why?
|
Polypharmacy | 1 | 2014 | 305 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2803 | 0.020 |
Why?
|
Observer Variation | 1 | 2017 | 2596 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2476 | 0.020 |
Why?
|
Strongyloides stercoralis | 1 | 2010 | 23 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3575 | 0.020 |
Why?
|
Prednisone | 1 | 2014 | 1564 | 0.020 |
Why?
|
Waiting Lists | 1 | 2014 | 741 | 0.020 |
Why?
|
Sex Factors | 1 | 2003 | 10491 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2018 | 2004 | 0.020 |
Why?
|
Rare Diseases | 1 | 2014 | 618 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2015 | 2849 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2503 | 0.020 |
Why?
|
Cryosurgery | 1 | 2014 | 469 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1614 | 0.020 |
Why?
|
Gene Expression | 1 | 2021 | 7582 | 0.020 |
Why?
|
Signal Transduction | 3 | 2018 | 23254 | 0.020 |
Why?
|
Quinazolines | 1 | 2015 | 1356 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 1397 | 0.020 |
Why?
|
Deglutition Disorders | 1 | 2014 | 623 | 0.020 |
Why?
|
Hot Temperature | 1 | 2014 | 1432 | 0.020 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2016 | 1585 | 0.020 |
Why?
|
Oncogenes | 1 | 2013 | 1218 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2013 | 3600 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5040 | 0.020 |
Why?
|
Prospective Studies | 2 | 2021 | 54040 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3588 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2021 | 12755 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 8014 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 2014 | 1214 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5780 | 0.020 |
Why?
|
Ultrasonography | 1 | 2018 | 5938 | 0.020 |
Why?
|
Sulfonamides | 1 | 2015 | 1970 | 0.020 |
Why?
|
RNA Interference | 1 | 2013 | 2843 | 0.010 |
Why?
|
Up-Regulation | 1 | 2013 | 4116 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2015 | 6523 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2013 | 6067 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10806 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2019 | 18929 | 0.010 |
Why?
|
Immunization | 1 | 2007 | 1217 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2014 | 2292 | 0.010 |
Why?
|
Recurrence | 1 | 2015 | 8456 | 0.010 |
Why?
|
Oxygen | 1 | 2014 | 4187 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3677 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8570 | 0.010 |
Why?
|
Cell Movement | 1 | 2013 | 5178 | 0.010 |
Why?
|
Vitamin D | 1 | 2014 | 3276 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15638 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41121 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15773 | 0.010 |
Why?
|
Schizophrenia | 1 | 2014 | 6897 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2007 | 4707 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16442 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2014 | 11876 | 0.010 |
Why?
|
Child, Preschool | 1 | 2014 | 41848 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2007 | 10059 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2013 | 20889 | 0.000 |
Why?
|